PREPARATION AND DISTRIBUTION OF RESEARCH DRUG PRODUCTS
PREPARATION AND DISTRIBUTION OF RESEARCH DRUG PRODUCTS
The National Institutes of Health, National Institute on Drug Abuse (NIDA) is soliciting proposals under solicitation number 75N95024R00003 for the preparation and distribution of research drug products. This initiative supports the NIDA Drug Supply Program by providing authentic controlled and uncontrolled drug compounds, dosage forms, and marijuana and nicotine research cigarettes to the addiction research community. The contractor will be responsible for acquiring, importing, developing, and manufacturing these substances—including morphine, methadone, naltrexone pellets, and various cannabinoid preparations—while performing frequent purity analysis and maintaining storage and distribution capabilities in compliance with DEA regulations.
Work under this requirement is categorized under NAICS 541715 for Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) and PSC AN11 for Health R&D Services; Health Care Services; Basic Research. Upon the issuance of task orders, the contractor will manage bulk drugs and chemical compounds to assist NIDA in promoting drug abuse and addiction research. Performance will take place in the United States, and the procurement documentation includes three attachments: the original solicitation and two subsequent amendments.
Responses to this solicitation are due by November 15, 2024. The primary point of contact for this requirement is Scott Duernberger. This solicitation was originally published on October 1, 2024, and was last updated on October 28, 2024.
Generated by Lumen AI
Scoped analysis and attachments—go beyond the summary when you need detail from the solicitation package.
Contact and place of performance
Scott Duernberger
USA
The NIDA Drug Supply Program plays a major role in promoting drug abuse and drug addiction research by providing to the drug abuse research community with a wide variety of authentic controlled and uncontrolled drug compounds, some of their dosage forms, and marijuana and nicotine research cigarettes for research. Through this contract NIDA plans to continue to acquire drug compounds, drug dosage forms for the NIDA d...
View more